Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Chronic Plaque Psoriasis (RaPsOdy) 2014-07-16 20:00
Aptuit Names Dr. Paul Overton Executive VP, Business Development & Marketing; Enhances Sterile Drug Product Capabilities 2014-07-16 02:20
CEM's Breakthrough High-Efficiency Peptide Synthesis Technology Wins R&D 100 Award 2014-07-15 21:00
Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2014-07-15 09:00
Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan 2014-07-14 21:41
NPCB Malaysia Issues GMP Certificate to Bilcare Global Clinical Supplies 2014-07-11 14:32
Abbott and Fonterra to Form Strategic Alliance for Dairy Farming in China 2014-07-11 02:17
Abbott Builds Long-Term Commitment in China 2014-07-11 02:01
Coherus BioSciences Appoints Dr. V. Bryan Lawlis, Jr. to Board of Directors 2014-07-09 20:00
Taipei Medical University-Taipei Cancer Center Offers a New and Noninvasive Treatment for Bone Cancer Pain 2014-07-04 10:00
AMRI Completes Acquisition of Oso Biopharmaceuticals Manufacturing 2014-07-02 04:22
Synageva BioPharma™ Reports Positive Top-Line Results From Phase 3 Study Of Sebelipase Alfa In Children And Adults With LAL Deficiency 2014-07-01 04:02
Economist Intelligence Unit Report Calls for Urgent Global Action to Combat the Growing Tuberculosis Pandemic 2014-06-30 20:53
Frost & Sullivan: Indonesia continues to be one of the more attractive markets in ASEAN for foreign healthcare companies 2014-06-28 18:00
CHMP Recommends Lilly and Boehringer Ingelheim's New Insulin Glargine Product for Approval in the European Union 2014-06-27 21:44
CPhI Istanbul Cements Rapid Pharma Sector Growth in Eurasia, Central Asia and MENA Regions 2014-06-26 22:00
NPCB Malaysia Issues GMP Certificate to Bilcare Global Clinical Supplies 2014-06-26 15:10
Frost & Sullivan: Companion Diagnostics Benefit from Fewer Regulatory Barriers in Europe 2014-06-24 20:14
Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Rheumatoid Arthritis 2014-06-24 06:57
JHL Biotech Closes $35 Million Series B Financing 2014-06-20 02:30
1 412 413 414 415 416